Elsevier

Drug and Alcohol Dependence

Volume 79, Issue 2, 1 August 2005, Pages 273-277
Drug and Alcohol Dependence

Short communication
Deficits in response inhibition associated with chronic methamphetamine abuse

https://doi.org/10.1016/j.drugalcdep.2005.02.002Get rights and content

Abstract

Chronic methamphetamine (MA) abuse is associated with cerebral deficits, involving frontal/basal-ganglia regions that are important for inhibitory control. We used the Stop-Signal Task to measure response inhibition in 11 MA abusers (5–7 days abstinent) and two groups of control subjects who did not use MA (14 tobacco smokers and 29 non-smokers). Stop-signal reaction time (SSRT), which indicates the latency to inhibit an initiated motor response, was significantly longer for MA abusers than for either control group (p's < .01). In contrast, the MA abusers did not differ from either group on Go trial reaction time (RT) or number of discrimination errors, which reflect motor speed and decision-processes, respectively. MA abuse in this study was therefore associated with a specific deficit in inhibiting a pre-potent response. Future research could examine whether SSRT is different for MA abusers who respond to treatment compared to those who do not. If such differences are established then response inhibition may serve as a marker for investigating MA abuse in basic science and clinical trials.

Introduction

Response inhibition can be defined as the intentional prevention of a behavior that is underway or that is otherwise automatically evoked (i.e., “pre-potent”). Experimentally, it can be studied with stop-signal, Go/No-Go and other inhibitory tasks. It has been hypothesized that response inhibition is relevant to the cessation of drug use because the suppression of rapid conditioned drug-seeking responses may occur by a similar mechanism as the suppression of a motor response (Fillmore, 2003; Jentsch and Taylor, 1999; Lyvers, 2000). Response inhibition has been consistently related to functional activation and structural integrity of the right inferior frontal cortex, and fairly consistently with the basal-ganglia (for review, see Aron et al., 2004; Aron and Poldrack, in press). Response inhibition may be particularly relevant to methamphetamine (MA) dependence given the range of frontal/basal-ganglia abnormalities observed in MA abusers, including low levels of dopamine transporter (McCann et al., 1998; Sekine et al., 2001, Sekine et al., 2003; Volkow et al., 2001b), low concentrations of cortical serotonin (Wilson et al., 1996), low concentrations of N-acetylaspartate (a marker for neuronal integrity) (Ernst et al., 2000), abnormalities in glucose metabolism (Volkow et al., 2001a; London et al., 2004), and deficits in gray matter relative to controls (Thompson et al., 2004).

The handful of neuropsychological reports on chronic MA abusers (Chang et al., 2002; Kalechstein et al., 2003; Paulus et al., 2003; Rogers et al., 1999; Salo et al., 2002; Simon et al., 2000) indicate impairment on measures associated with frontal cortical functioning, including verbal and non-verbal fluency (see Kalechstein et al., 2003) and working memory (Chang et al., 2002; Simon et al., 2000). Response inhibition among MA abusers has primarily been assessed in past studies using paper or computer versions of the Stroop Color-Word Task (Perret, 1974), which requires inhibition of reading color names. Both Simon et al. (2000) and Salo et al. (2002) reported impairment on Stroop performance among MA users, while Kalechstein et al. (2003) and Chang et al. (2002) did not find significant deficits among MA abusers on the task. The discrepancy between these studies may reflect variability given an underlying modest effect, or may be related to methodological differences; only Salo et al. (2002) used a voice-sensitive trial-based computerized version of the task, and only Simon et al. included MA abusers who tested positive for MA on the day of testing.

Compared with the Stroop Task, the Stop-Signal Task is a more direct means of assessing response inhibition (Logan et al., 1984, Logan et al., 1997; Nigg, 2000; Quay, 1997). Through a method described below, the Stop-Signal Task measures the amount of time (typically on the order of 200 ms) required to inhibit a motor response already initiated. Several lines of evidence suggest that this measure may relate to clinically relevant behavior and pathology. First, individuals with attention deficit hyperactivity disorder do poorly on the task (see Nigg, 2000 for review), and their performance improves following administration of methylphenidate (Tannock et al., 1995). Second, poor performance on the task is correlated with greater ratings of impulsivity on a personality scale (Tannock et al., 1995). And third, cocaine abusers perform poorly on the task relative to controls (Fillmore and Rush, 2002). Consistent with the notion that Stroop Task performance is mediated by a variety of factors other than response inhibition (for review, see MacLeod, 1991) performance on the Stop-Signal Task does not appear to be well correlated with performance on the Stroop Task (in Friedman and Miyake (2004) r = .15; in Avila et al. (2004), r = −.11).

The purpose of this study was to assess whether MA abusers would demonstrate slower stop-signal response inhibition than control subjects and whether individual differences among MA abusers in response inhibition would be correlated with duration and extent of MA abuse.

Section snippets

Participants

Since cigarette smoking is common among MA abusers (e.g., London et al., 2004), we recruited and took informed consent (in accordance with the Human Subjects Protection Committee of UCLA) from both a group of control smokers (n = 14), and control non-smokers (n = 29) for comparison with a group of MA abusers (n = 11). Inclusion in the MA group required testing positive for recent MA use (and not other illicit drugs), reporting 1 or more years of using ≥1 g of MA per week, and meeting DSM-IV criteria

Results

Success on stop-signal trials was 48.3% and did not differ across groups, indicating that the titration procedure was successful. One-way analyses of variance indicated no significant difference across groups in reaction times (F(2, 51) = .51, p = .62), or in error rates (F(2, 51) = 2.2, p = .13) on Go trials. A main effect was observed on SSRT (F(2, 51) = 13.7, p < .001). Post hoc analyses (using the Bonferroni correction) indicated that MA participants had slower SSRTs than both control groups (p's < .01),

Discussion

This study shows slower response inhibition among recently abstinent MA abusers on the Stop-Signal Task relative to healthy control subjects. A small group (n = 11) of recently abstinent MA abusers exhibited markedly worse performance than either comparison group on response inhibition, but not on reaction times or errors on non-inhibition trials. The results also suggest that individual differences among MA abusers in response inhibition are related to the recent amount of MA use. Given that the

Acknowledgements

Supported by NIH Grant K01 DA0051-01A1 (JM), NIH Grant 3R01 DA015179-02S1 (EDL), and UCLA NIH-supported General Clinical Research Center 5M01RR000865-31.

References (33)

  • T. Ernst et al.

    Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study

    Neurology

    (2000)
  • W. Fals-Stewart

    Neurocognitive defects and their impact on substance abuse treatment

    J. Addict. Offend. Counsel.

    (1993)
  • M.T. Fillmore

    Drug abuse as a problem of impaired control: current approaches and findings

    Behav. Cogn. Neurosci. Rev.

    (2003)
  • N.P. Friedman et al.

    The relations among inhibition and interference control functions: a latent-variable analysis

    J. Exp. Psychol. Gen.

    (2004)
  • J.D. Jentsch et al.

    Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli

    Psychopharmacy (Berlin)

    (1999)
  • A.D. Kalechstein et al.

    Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence

    J. Neuropsychiatry Clin. Neurosci.

    (2003)
  • Cited by (308)

    View all citing articles on Scopus
    View full text